HORMONAL REPLACEMENT THERAPY AFTER SURGICAL MENOPAUSE by Yakov, M.
Scripta Scientifica Medica, vol.28, Suppl.1,pp.145-146 
Copyright © Medical University, Varna, 1991 
HORMONAL REPLACEMENT THERAPY AFTER SURGICAL 
MENOPAUSE 
M. Yakov 
Department of Obstetrics and Gynecology, Varna 
Bilateral oophorectomy performed before menopause causes 
profound changes in the female, an immediate sign of which is the 
fall of sex hormones concentrations. Along with hormonal changes, 
abnormalities in metabolism, osteporosis, vasomotor, circulatory, 
psychosomatic and sexual disturbances arise, consisting in this way 
the menopausal syndrome. 
The present study aims at determining: 1. the frequency of some 
menopausal symptoms following surgical castration; 2. the serum 
concentrations of FSH, LH, oestradiol (E2), uric acid and their rela-
tion to these symptoms, and 3. the effect of estrogen replacement 
therapy (ERT) on the investigated symptoms. 
FSH, LH, E2 and uric asid concentrations were investigated in 
45 women undergone total hysterectomy with bilateral adnexectomy 
for benign gynecological diseases. Blood samples were taken right 
before the surgery, 10 days, 3 months and 6 months later. Patients 
were randomly distributed in two groups. The study group consisted 
of 25 women who were treated with Progynon Depot 10 mg i.m. twice 
monthly since the middle of the first till the end of the sixth month 
after the operation. The patients in the control group (20) have not 
been treated hormonally. No significant difference between both 
groups average age, education and social statute was found out. The 
relations between the E2 and uric acid serum levels and vasomotor 
complaints (hot flushes, night perspirations), sexual disturbancies 
(libido, vaginal lubrication, coitus frequency and orgasm) and de-
pression were analysed. All the patients were interviewed and in-
formed concent was obtained. Selfrating depression scale of Zung 
was used. Variance analysis and check up hypothesis test were ap-
plied to assess the data obtained. 
E2 drops to a very low level (from 323 to 18 pmol/l) immediate-
ly after the operation. In the control group these concentrations re-
main approximately at the same level (24-30 pmol/l) while in the . 
estrogen treated group E2 rises back to the premenopausal values. 
Ten days after the oophorectomy FSH and LH serum concentrations 
rise steeply 5-6 times (24 jxg/l and 23 IU/I, respectively). In the con-
trol group these values rise twice till the end of the first month and 
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stay at this level till the end of the investigated period. Immediately 
after the estrogen replacement (ER) FSH and LH drop approximate-
ly to the preoperative levels (5 |xg/l and 12,4 IU/I). 28% of the women 
with ER had vasomotor complaints v. s. 85% in the control group. 
Sexual disordeds frequency is significantly higher (p<0,05) in the 
untreated group, too (55% v.s. 36%). Symptoms of depression we 
found equally in both groups - 60%. Correlation between E2 concen-
trations and vasomotor and sexual complaints was established but 
great differences in the E2 levels encouraged us to look for other fac-
tors influencing on the investigated symptoms. According to Menon 
et al. (1987), this could be uric acid. 
We found significamtly higher serum concentrations in patients 
with vasomotor complaints (268 |xmol/l v.s. 211 |imol/l) (p<0,05). 
85% of the patients after surgical castration have menopausal com-
plaints but only 25-30% tend to seek medical advice. ER improves 
sexual and vasomotor complaints, though it is not only a conse-
quence of the elevated E2 concentrations. The menopausal syn-
drome is a polysymptomatic complex influenced not only by 
gonadotrophic and sexual hormones changes but also by different 
metabolic disorders. The rising female average age and surgical 
menopause rate make its further investigation up-to-date. 
